Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer.

International journal of clinical and experimental pathology - 1 Jan 2015

Ming Jie, Liu Zeming, Zeng Wen, Maimaiti Yusufu, Guo Yawen, Nie Xiu, Chen Chen, Zhao Xiangwang, Shi Lan, Liu Chunping, Huang Tao

Abstract excerpt

OBJECTIVE: To evaluate the significance of BRAF (V600E) and Ras mutations, and RET rearrangements in papillary thyroid cancer (PTC) in the South central region of China. METHODS: We included patients from Union hospital's pathology archive diagnosed with PTC and meeting the criteria for BRAF mutation, RAS mutation, and RET rearrangement testing. Medical records were analyzed for BRAF and RAS mutation status, RET...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Carcinoma, Papillary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Rearrangement

Share to Nuclear Proteins

Share to Proto-Oncogene Proteins B-raf

Share to ras Proteins

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 26823860
PMCID: PMC4713646

Genes

BRAF
RET

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer.PMID 26823860Read ↗

Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case seriesSemantic proximity Read ↗

The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese PopulationSemantic proximity Read ↗

The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review.Semantic proximity Read ↗

BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.Semantic proximity Read ↗

Roles of RAS and BRAF mutations in thyroid carcinogenesis.Semantic proximity Read ↗

The Association of the BRAF V600E Mutation with Clinicopathologic Characteristics in Chinese Population with Conventional Papillary Thyroid CarcinomaSemantic proximity Read ↗

The association between BRAF (V600E) mutation and pathological features in PTC.Semantic proximity Read ↗

Clinical significance of BRAF mutation in thyroid papillary cancer.Semantic proximity Read ↗

Various Roles of Hashimoto's Thyroiditis and Thyroid Function in Papillary Thyroid Micro- and Macro-carcinomaSemantic proximity Read ↗

Analysis of the association of BRAFV600E mutation and Ki-67 overexpression with clinical and pathological characteristics in papillary thyroid cancer.Semantic proximity Read ↗

Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features.Semantic proximity Read ↗

Targeting of the BRAF gene in papillary thyroid carcinoma (review).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.